Eos BioTechnolgy develops antibody-based therapeutics, medium density oligo spotted microarrays, oligonucleotide synthesis

History:

They were acquired by Protein Design Labs in 2003

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Northern California

Research Focus:
Microarray/Chip Technologies Disease Therapeutics-Research Therapeutics-Development

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: